ArticlePloS one2022

Development of an advance directive 'communication tool' relevant for patients with advanced cancer in six European countries: Experiences from the ACTION trial.

Caroline Moeller Arnfeldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.